Results 11 to 20 of about 754,926 (313)

Efficacy of Intra-Articular Injection of Botulinum Toxin Type A (IncobotulinumtoxinA) in Temporomandibular Joint Osteoarthritis: A Three-Arm Controlled Trial in Rats

open access: yesToxins, 2023
Temporomandibular disorders (TMD) are complex pathologies responsible for chronic orofacial pain. Intramuscular injection of botulinum toxin A (BoNT/A) has shown effectiveness in knee and shoulder osteoarthritis, as well as in some TMDs such as ...
Marie Béret   +6 more
doaj   +1 more source

Stomaching Drug Delivery [PDF]

open access: yesNew England Journal of Medicine, 2019
The Tortoise and the Tummy The gastric mucosa represents a formidable barrier to oral drug delivery.
David J. Brayden, Alan W. Baird
openaire   +5 more sources

Sequential delivery of PD-1/PD-L1 blockade peptide and IDO inhibitor for immunosuppressive microenvironment remodeling via an MMP-2 responsive dual-targeting liposome

open access: yesActa Pharmaceutica Sinica B, 2023
Intelligent responsive drug delivery system opens up new avenues for realizing safer and more effective combination immunotherapy. Herein, a kind of tumor cascade-targeted responsive liposome (NLG919@Lip-pep1) is developed by conjugating polypeptide ...
Chuan Hu   +8 more
doaj   +1 more source

Microfabrication for Drug Delivery [PDF]

open access: yesMaterials, 2016
This review is devoted to discussing the application of microfabrication technologies to target challenges encountered in life processes by the development of drug delivery systems. Recently, microfabrication has been largely applied to solve health and pharmaceutical science issues.
Brendan Koch   +4 more
openaire   +3 more sources

Development of α-Tocopherol Succinate-Based Nanostructured Lipid Carriers for Delivery of Paclitaxel

open access: yesPharmaceutics, 2022
The management of retinoblastoma (RB) involves the use of invasive treatment regimens. Paclitaxel (PTX), an effective antineoplastic compound used in the treatment of a wide range of malignant tumors, poses treatment challenges due to systemic toxicity ...
Sushrut Marathe   +5 more
doaj   +1 more source

Positive-charge tuned gelatin hydrogel-siSPARC injectable for siRNA anti-scarring therapy in post glaucoma filtration surgery

open access: yesScientific Reports, 2021
Small interfering RNA (siRNA) therapy is a promising epigenetic silencing strategy. However, its widespread adoption has been severely impeded by its ineffective delivery into the cellular environment.
Yong Yao Chun   +8 more
doaj   +1 more source

Nanofibres in Drug Delivery [PDF]

open access: yes, 2018
In recent years there has been an explosion of interest in the production of nanoscale fibres for drug delivery and tissue engineering. Nanofibres in Drug Delivery aims to outline to new researchers in the field the utility of nanofibres in drug delivery, and to explain to them how to prepare fibres in the laboratory.
Williams, GH, Raimi-Abraham, BT, Luo, C
openaire   +5 more sources

Transfollicular Drug Delivery [PDF]

open access: yesPharmaceutical Research, 1995
The hair follicle, hair shaft, and sebaceous gland collectively form what is recognized as the pilosebaceous unit. This complex, three-dimensional structure within the skin possesses a unique biochemistry, metabolism and immunology. Recent studies have focused on the hair follicle as a potential pathway for both localized and systemic drug delivery ...
Lauer, Andrea C.   +4 more
openaire   +4 more sources

New generation of DNA-based immunotherapy induces a potent immune response and increases the survival in different tumor models

open access: yesJournal for ImmunoTherapy of Cancer, 2021
Background Strategies to increase nucleic acid vaccine immunogenicity are needed to move towards clinical applications in oncology. In this study, we designed a new generation of DNA vaccines, encoding an engineered vesicular stomatitis virus ...
Alessandra Lopes   +8 more
doaj   +1 more source

Dendrimers for Drug Delivery [PDF]

open access: yesMolecules, 2018
Dendrimers have come a long way in the last 25 years since their inception. Originally created as a wonder molecule of chemistry, dendrimer is now in the fourth class of polymers. Dr. Donald Tomalia first published his seminal work on Poly(amidoamine) (PAMAM) dendrimers in 1985. Application of dendrimers as a drug delivery system started in late 1990s.
openaire   +4 more sources

Home - About - Disclaimer - Privacy